Literature DB >> 20465436

Mediators and mechanisms of herpes simplex virus entry into ocular cells.

Asim V Farooq1, Tibor Valyi-Nagy, Deepak Shukla.   

Abstract

The entry of herpes simplex virus into cells was once thought to be a general process. It is now understood that the virus is able to use multiple mechanisms for entry and spread, including the use of receptors and co-receptors that have been determined to be cell-type specific. This is certainly true for ocular cell types, which is important as the virus may use different mechanisms to gain access to multiple anatomic structures in close proximity, leading to various ocular diseases. There are some patterns that may be utilized by the virus in the eye and elsewhere, including surfing along filopodia in moving from cell to cell. There are common themes as well as intriguing differences in the entry mechanisms of herpes simplex virus into ocular cells. We discuss these issues in the context of conjunctivitis, keratitis, acute retinal necrosis, and other ocular diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20465436      PMCID: PMC2902162          DOI: 10.3109/02713681003734841

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  45 in total

1.  The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells.

Authors:  Edward A Burton; Chang-Sook Hong; Joseph C Glorioso
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 2.  Dissecting virus entry via endocytosis.

Authors:  Sara B Sieczkarski; Gary R Whittaker
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

Review 3.  Herpes simplex virus: receptors and ligands for cell entry.

Authors:  Patricia G Spear
Journal:  Cell Microbiol       Date:  2004-05       Impact factor: 3.715

4.  Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.

Authors:  D A Leib; D M Coen; C L Bogard; K A Hicks; D R Yager; D M Knipe; K L Tyler; P A Schaffer
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982.

Authors:  T J Liesegang; L J Melton; P J Daly; D M Ilstrup
Journal:  Arch Ophthalmol       Date:  1989-08

6.  Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.

Authors:  Lies Remeijer; Jeroen Maertzdorf; Johannes Buitenwerf; Albert D M E Osterhaus; Georges M G M Verjans
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-02       Impact factor: 4.799

7.  Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology.

Authors:  C K Newell; S Martin; D Sendele; C M Mercadal; B T Rouse
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study.

Authors:  W G Hodge; T P Margolis
Journal:  Ophthalmology       Date:  1997-01       Impact factor: 12.079

9.  Herpes simplex keratitis in patients with acquired immune deficiency syndrome.

Authors:  T L Young; J B Robin; G N Holland; R L Hendricks; J F Paschal; R E Engstrom; J Sugar
Journal:  Ophthalmology       Date:  1989-10       Impact factor: 12.079

10.  Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis.

Authors:  David R Lairson; Charles E Begley; Thomas F Reynolds; Kirk R Wilhelmus
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  22 in total

Review 1.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.

Authors:  Kening Wang; Georgia D Tomaras; Sinthujan Jegaskanda; M Anthony Moody; Hua-Xin Liao; Kyle N Goodman; Phillip W Berman; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayapan; Jaranit Kaewkungwal; Barton F Haynes; Jeffrey I Cohen
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils.

Authors:  Derek J Royer; Min Zheng; Christopher D Conrady; Daniel J J Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

4.  Prior inhibition of AKT phosphorylation by BX795 can define a safer strategy to prevent herpes simplex virus-1 infection of the eye.

Authors:  Tejabhiram Yadavalli; Rahul Suryawanshi; Marwan Ali; Aqsa Iqbal; Raghuram Koganti; Joshua Ames; Vinay Kumar Aakalu; Deepak Shukla
Journal:  Ocul Surf       Date:  2019-11-23       Impact factor: 5.033

Review 5.  Update on Herpes simplex keratitis management.

Authors:  Daniel Sibley; Daniel F P Larkin
Journal:  Eye (Lond)       Date:  2020-08-25       Impact factor: 3.775

6.  High Frequency of Gamma Interferon-Producing PLZFloRORγtlo Invariant Natural Killer 1 Cells Infiltrating Herpes Simplex Virus 1-Infected Corneas Is Associated with Asymptomatic Ocular Herpesvirus Infection.

Authors:  Nisha R Dhanushkodi; Ruchi Srivastava; Swayam Prakash; Soumyabrata Roy; Pierre-Gregoire A Coulon; Hawa Vahed; Angela M Nguyen; Stephanie Salazar; Lan Nguyen; Cassandra Amezquita; Caitlin Ye; Vivianna Nguyen; Lbachir BenMohamed
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

Review 7.  Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea.

Authors:  Lulia Koujah; Rahul K Suryawanshi; Deepak Shukla
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

8.  HSV-1 infection of human corneal epithelial cells: receptor-mediated entry and trends of re-infection.

Authors:  Arpeet Shah; Asim V Farooq; Vaibhav Tiwari; Min-Jung Kim; Deepak Shukla
Journal:  Mol Vis       Date:  2010-11-20       Impact factor: 2.367

9.  Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107+ CD8+ T Cells That Infiltrate the Corneas and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protect against Ocular Herpes Challenge.

Authors:  Arif A Khan; Ruchi Srivastava; Hawa Vahed; Soumyabrata Roy; Sager S Walia; Grace J Kim; Mona A Fouladi; Taikun Yamada; Vincent T Ly; Cynthia Lam; Anthony Lou; Vivianna Nguyen; Undariya Boldbaatar; Roger Geertsema; Nigel W Fraser; Lbachir BenMohamed
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

10.  Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.

Authors:  Oleg Alekseev; Kelly Donovan; Jane Azizkhan-Clifford
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.